Biomedical Microdevices

, Volume 15, Issue 4, pp 595–609 | Cite as

Microfluidics and cancer: are we there yet?

Article

Abstract

More than two decades ago, microfluidics began to show its impact in biological research. Since then, the field of microfluidics has evolving rapidly. Cancer is one of the leading causes of death worldwide. Microfluidics holds great promise in cancer diagnosis and also serves as an emerging tool for understanding cancer biology. Microfluidics can be valuable for cancer investigation due to its high sensitivity, high throughput, less material-consumption, low cost, and enhanced spatio-temporal control. The physical laws on microscale offer an advantage enabling the control of physics, biology, chemistry and physiology at cellular level. Furthermore, microfluidic based platforms are portable and can be easily designed for point-of-care diagnostics. Developing and applying the state of the art microfluidic technologies to address the unmet challenges in cancer can expand the horizons of not only fundamental biology but also the management of disease and patient care. Despite the various microfluidic technologies available in the field, few have been tested clinically, which can be attributed to the various challenges existing in bridging the gap between the emerging technology and real world applications. We present a review of role of microlfuidcs in cancer research, including the history, recent advances and future directions to explore where the field stand currently in addressing complex clinical challenges and future of it. This review identifies four critical areas in cancer research, in which microfluidics can change the current paradigm. These include cancer cell isolation, molecular diagnostics, tumor biology and high-throughput screening for therapeutics. In addition, some of our lab’s current research is presented in the corresponding sections.

Keywords

Microfluidics Cancer Cancer diagnostics Circulating tumor cells Tumor biology Bio MEMS Cancer therapeutics 

References

  1. F. Alexis, J.W. Rhee, J.P. Richie, A.F. Radovic-Moreno, R. Langer, O.C. Farokhzad, New frontiers in nanotechnology for cancer treatment. Urol. Oncol. 26(1), 74–85 (2008)CrossRefGoogle Scholar
  2. W.J. Allard, Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 10(20), 6897–6904 (2004)CrossRefGoogle Scholar
  3. P.A. Auroux et al., Micro total analysis systems. 2. Analytical standard operations and applications. Anal. Chem. 74(12), 2637–2652 (2002)CrossRefGoogle Scholar
  4. P.A. Baeuerle, O. Gires, EpCAM (CD326) finding its role in cancer. Br. J. Cancer 96(3), 417–423 (2007)CrossRefGoogle Scholar
  5. E. Brouzes et al., Droplet microfluidic technology for single-cell high-throughput screening. Proc. Natl. Acad. Sci. U. S. A. 106(34), 14195–14200 (2009)CrossRefGoogle Scholar
  6. S.D. Chan et al., Cytometric analysis of protein expression and apoptosis in human primary cells with a novel microfluidic chip-based system. Cytom. A 55(2), 119–125 (2003)CrossRefGoogle Scholar
  7. K.C. Chaw et al., A quantitative observation and imaging of single tumor cell migration and deformation using a multi-gap microfluidic device representing the blood vessel. Microvasc. Res. 72(3), 153–160 (2006)CrossRefGoogle Scholar
  8. K.C. Chaw et al., Multi-step microfluidic device for studying cancer metastasis. Lab Chip 7(8), 1041–1047 (2007)CrossRefGoogle Scholar
  9. C. Chen et al., Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip 10(4), 505–511 (2010)CrossRefMathSciNetGoogle Scholar
  10. C.L. Chen et al., Separation and detection of rare cells in a microfluidic disk via negative selection. Lab Chip 11(3), 474–483 (2011)CrossRefGoogle Scholar
  11. J. Cheng et al., Isolation of cultured cervical carcinoma cells mixed with peripheral blood cells on a bioelectronic chip. Anal. Chem. 70(11), 2321–2326 (1998)CrossRefGoogle Scholar
  12. D.T. Chiu et al., Patterned deposition of cells and proteins onto surfaces by using three-dimensional microfluidic systems. Proc. Natl. Acad. Sci. U. S. A. 97(6), 2408–2413 (2000)CrossRefGoogle Scholar
  13. S. Chung et al., Cell migration into scaffolds under co-culture conditions in a microfluidic platform. Lab Chip 9(2), 269–275 (2009)CrossRefGoogle Scholar
  14. J. den Toonder, Circulating tumor cells: the grand challenge. Lab Chip 11(3), 375–377 (2011)CrossRefGoogle Scholar
  15. J. DeRisi, P.S. Meltzer, L. Penland, P.O. Brown (Group 1); M.L. Bittner, M. Ray, Y. Chen, Y.A. Su, J.M. Trent (Group 2). Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 14, 457–460 (1996)CrossRefGoogle Scholar
  16. U. Dharmasiri et al., Highly efficient capture and enumeration of low abundance prostate cancer cells using prostate-specific membrane antigen aptamers immobilized to a polymeric microfluidic device. Electrophoresis 30(18), 3289–3300 (2009)CrossRefGoogle Scholar
  17. U. Dharmasiri et al., High-throughput selection, enumeration, electrokinetic manipulation, and molecular profiling of low-abundance circulating tumor cells using a microfluidic system. Anal. Chem. 83(6), 2301–2309 (2011)CrossRefGoogle Scholar
  18. D. Di Carlo, L.Y. Wu, L.P. Lee, Dynamic single cell culture array. Lab Chip 6(11), 1445–1449 (2006)CrossRefGoogle Scholar
  19. F. Diehl et al., Circulating mutant DNA to assess tumor dynamics. Nat. Med. 14(9), 985–990 (2008)CrossRefGoogle Scholar
  20. M. Domenech et al., Cellular observations enabled by microculture: paracrine signaling and population demographics. Integr. Biol. (Camb.) 1(3), 267–274 (2009)CrossRefGoogle Scholar
  21. M. Domenech et al., Hedgehog signaling in myofibroblasts directly promotes prostate tumor cell growth. Integr. Biol. (Camb.) 4(2), 142–152 (2012)CrossRefGoogle Scholar
  22. J. El-Ali, P.K. Sorger, K.F. Jensen, Cells on chips. Nature 442(7101), 403–411 (2006)CrossRefGoogle Scholar
  23. A. Esquela-Kerscher, F.J. Slack, Oncomirs—microRNAs with a role in cancer. Nat. Rev. Cancer 6(4), 259–269 (2006)CrossRefGoogle Scholar
  24. T.K. Fabian, P. Fejerdy, P. Csermely, Salivary genomics, transcriptomics and proteomics: the emerging concept of the oral ecosystem and their use in the early diagnosis of cancer and other diseases. Curr. Genomics 9(1), 11–21 (2008)CrossRefGoogle Scholar
  25. R. Fan et al., Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood. Nat. Biotechnol. 26(12), 1373–1378 (2008)CrossRefGoogle Scholar
  26. B. Fang, M. Zborowski, L.R. Moore, Detection of rare MCF-7 breast carcinoma cells from mixtures of human peripheral leukocytes by magnetic deposition analysis. Cytometry 36(4), 294–302 (1999)CrossRefGoogle Scholar
  27. M. Ferrari, Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 5(3), 161–171 (2005)CrossRefGoogle Scholar
  28. G.D. Gasperis et al., Microfuidic cell separation by 2D dielectrophoresis. Biomed. Microdevices 2(1), 41–49 (1999)CrossRefGoogle Scholar
  29. J.P. Gleghorn et al., Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody. Lab Chip 10(1), 27 (2010)CrossRefGoogle Scholar
  30. D. Hanahan, R.A. Weinberg, The hallmarks of cancer. Cell 100(1), 57–70 (2000)CrossRefGoogle Scholar
  31. J.R. Heath, M.E. Davis, Nanotechnology and cancer. Annu. Rev. Med. 59, 251–265 (2008)CrossRefGoogle Scholar
  32. J.D. Hoheisel et al., Circulating Micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One 7(1), e29770 (2012)CrossRefGoogle Scholar
  33. J.W. Hong, S.R. Quake, Integrated nanoliter systems. Nat. Biotechnol. 21(10), 1179–1183 (2003)CrossRefGoogle Scholar
  34. K. Hoshino et al., Microchip-based immunomagnetic detection of circulating tumor cells. Lab Chip 11(20), 3449–3457 (2011)CrossRefGoogle Scholar
  35. H.W. Hou et al., Microfluidic devices for blood fractionation. Micromachines 2(3), 319–343 (2011)CrossRefGoogle Scholar
  36. A.Y. Hsiao et al., Microfluidic system for formation of PC-3 prostate cancer co-culture spheroids. Biomaterials 30(16), 3020–3027 (2009)CrossRefGoogle Scholar
  37. C.P. Huang et al., Engineering microscale cellular niches for three-dimensional multicellular co-cultures. Lab Chip 9(12), 1740–1748 (2009)CrossRefGoogle Scholar
  38. Y. Huang et al., Evaluation of cancer stem cell migration using compartmentalizing microfluidic devices and live cell imaging. J. Visual. Exp. 58 (2011)Google Scholar
  39. D. Huh et al., Microfluidics for flow cytometric analysis of cells and particles. Physiol. Meas. 26(3), R73–R98 (2005)CrossRefGoogle Scholar
  40. P.J. Hung et al., Continuous perfusion microfluidic cell culture array for high-throughput cell-based assays. Biotechnol. Bioeng. 89(1), 1–8 (2005)CrossRefGoogle Scholar
  41. S.C. Hur et al., Deformability-based cell classification and enrichment using inertial microfluidics. Lab Chip 11(5), 912–920 (2011)CrossRefGoogle Scholar
  42. D. Irimia, M. Toner, Spontaneous migration of cancer cells under conditions of mechanical confinement. Integr. Biol. (Camb.) 1(8–9), 506–512 (2009)CrossRefGoogle Scholar
  43. A. Jemal et al., Global cancer statistics. CA Cancer J. Clin. 61(2), 69–90 (2011)CrossRefGoogle Scholar
  44. J.V. Jokerst et al., Nano-bio-chips for high performance multiplexed protein detection: determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels. Biosens. Bioelectron. 24(12), 3622–3629 (2009)CrossRefGoogle Scholar
  45. J. Kaiser, Medicine. Cancer’s circulation problem. Science 327(5969), 1072–1074 (2010)CrossRefGoogle Scholar
  46. J.H. Kang et al., A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells. Lab Chip (2012a)Google Scholar
  47. J.H. Kang et al., A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells. Lab Chip 12(12), 2175–2181 (2012b)CrossRefGoogle Scholar
  48. J. Kim et al., A programmable microfluidic cell array for combinatorial drug screening. Lab Chip (2012)Google Scholar
  49. R.T. Krivacic et al., A rare-cell detector for cancer. Proc. Natl. Acad. Sci. U. S. A. 101(29), 10501–10504 (2004)CrossRefGoogle Scholar
  50. J.S. Kuo et al., Deformability considerations in filtration of biological cells. Lab Chip 10(7), 837–842 (2010)CrossRefGoogle Scholar
  51. E.J. Lim et al., Visualization of microscale particle focusing in diluted and whole blood using particle trajectory analysis. Lab Chip 12(12), 2199 (2012)CrossRefGoogle Scholar
  52. L. Liu et al., A microfluidic device for continuous cancer cell culture and passage with hydrodynamic forces. Lab Chip 10(14), 1807–1813 (2010)CrossRefGoogle Scholar
  53. S. Maheswaran, D.A. Haber, Circulating tumor cells: a window into cancer biology and metastasis. Curr. Opin. Genet. Dev. 20(1), 96–99 (2010)CrossRefGoogle Scholar
  54. S. Maheswaran et al., Detection of mutations in EGFR in circulating lung-cancer cells. N. Engl. J. Med. 359(4), 366–377 (2008)CrossRefGoogle Scholar
  55. A. Manz et al., Planar chips technology for miniaturization and integration of separation techniques into monitoring systems: capillary electrophoresis on a chip. J. Chromatogr. 593, 253–258 (1992)CrossRefGoogle Scholar
  56. O.J. Miller, A. El Harrak, T. Mangeat, J.-C. Baret, L. Frenz, B. El Debs, E. Mayot, M.L. Samuels, E.K. Rooney, P. Dieu, M. Galvan, D.R. Link, A.D. Griffiths, High-resolution dose–response screening using droplet-based microfluidics. PNAS 109(2), 378–383 (2012)CrossRefGoogle Scholar
  57. P.S. Mitchell et al., Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. 105(30), 10513–10518 (2008)CrossRefGoogle Scholar
  58. H. Mohamed et al., Development of a rare cell fractionation device: application for cancer detection. IEEE Trans. Nanobiosci. 3(4), 251–256 (2004)CrossRefGoogle Scholar
  59. H. Mohamed, M. Murray, J.N. Turner, M. Caggana, Circulating tumor cells: captured with a micromachined device. NSTI-Nanotech 1 (2005)Google Scholar
  60. H.-S. Moon et al., Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP). Lab Chip 11(6), 1118 (2011)CrossRefGoogle Scholar
  61. N.A. Mousa et al., Droplet-scale estrogen assays in breast tissue, blood, and serum. Sci. Transl. Med. 1(1), 1ra2 (2009)MathSciNetCrossRefGoogle Scholar
  62. J.H. Myung et al., Enhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM: implications for the effective separation of circulating tumor cells (CTCs). Langmuir 26(11), 8589–8596 (2010)CrossRefGoogle Scholar
  63. S. Nagrath et al., Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450(7173), 1235–1239 (2007)CrossRefGoogle Scholar
  64. D.X. Nguyen, J. Massagué, Genetic determinants of cancer metastasis. Nat. Rev. Genet. 8(5), 341–352 (2007)CrossRefGoogle Scholar
  65. M. Nora Dickson et al., Efficient capture of circulating tumor cells with a novel immunocytochemical microfluidic device. Biomicrofluidics 5(3), 34119–3411915 (2011)CrossRefGoogle Scholar
  66. R. Pal et al., An integrated microfluidic device for influenza and other genetic analyses. Lab Chip 5(10), 1024–1032 (2005)CrossRefGoogle Scholar
  67. D. Pekin et al., Quantitative and sensitive detection of rare mutations using droplet-based microfluidics. Lab Chip 11(13), 2156–2166 (2011)CrossRefGoogle Scholar
  68. J. Ratajczak et al., Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20(9), 1487–1495 (2006)CrossRefGoogle Scholar
  69. D.R. Reyes et al., Micro total analysis systems. 1. Introduction, theory, and technology. Anal. Chem. 74(12), 2623–2636 (2002)CrossRefGoogle Scholar
  70. M. Roessler, Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer. Clin. Cancer Res. 11(18), 6550–6557 (2005)MathSciNetCrossRefGoogle Scholar
  71. A.E. Saliba et al., Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays. Proc. Natl. Acad. Sci. U. S. A. 107(33), 14524–14529 (2010)CrossRefGoogle Scholar
  72. J. Santos et al., Molecular biomarker analyses using circulating tumor cells. PLoS One 5(9), e12517 (2010)CrossRefGoogle Scholar
  73. E. Schattner, A chip against cancer. Sci. Am. 300(4), 21–22 (2009)CrossRefGoogle Scholar
  74. R. Seigneuric et al., From nanotechnology to nanomedicine: applications to cancer research. Curr. Mol. Med. 10(7), 640–652 (2010)CrossRefGoogle Scholar
  75. S.K. Sia, G.M. Whitesides, Microfluidic devices fabricated in poly(dimethylsiloxane) for biological studies. Electrophoresis 24(21), 3563–3576 (2003)CrossRefGoogle Scholar
  76. R. Siegel et al., Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin. 61(4), 212–236 (2011)CrossRefGoogle Scholar
  77. A.M. Sieuwerts et al., Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J. Natl. Cancer Inst. 101(1), 61–66 (2009)CrossRefGoogle Scholar
  78. J.W. Song et al., Microfluidic endothelium for studying the intravascular adhesion of metastatic breast cancer cells. PLoS One 4(6), e5756 (2009)CrossRefGoogle Scholar
  79. P.K. Sorger, Microfluidics closes in on point-of-care assays. Nat. Biotechnol. 26(12), 1345–1346 (2008)CrossRefGoogle Scholar
  80. E. Stern et al., Label-free biomarker detection from whole blood. Nat. Nanotechnol. 5(2), 138–142 (2010)MathSciNetCrossRefGoogle Scholar
  81. S.L. Stott et al., Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci. Transl. Med. 2(25), 25ra23 (2010a)CrossRefGoogle Scholar
  82. S.L. Stott, C.-H. Hsu, D.I. Tsukrov, M. Yud, D.T. Miyamoto, B.A. Waltman et al., Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. PNAS 107(43), 18392–18397 (2010b)CrossRefGoogle Scholar
  83. J.H. Sung, M.L. Shuler, Microtechnology for mimicking in vivo tissue environment. Ann. Biomed. Eng. 40(6), 1289–1300 (2012)CrossRefGoogle Scholar
  84. K.E. Sung et al., Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects. Integr. Biol. (Camb.) 3(4), 439–450 (2011)CrossRefGoogle Scholar
  85. S. Takayama et al., Subcellular positioning of small molecules. Nature 411(6841), 1016 (2001)CrossRefGoogle Scholar
  86. S. Takayama et al., Selective chemical treatment of cellular microdomains using multiple laminar streams. Chem. Biol. 10(2), 123–130 (2003)CrossRefGoogle Scholar
  87. A.H. Talasaz et al., Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc. Natl. Acad. Sci. 106(10), 3970–3975 (2009)CrossRefGoogle Scholar
  88. D.D. Taylor, C. Gerçel-Taylor, Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br. J. Cancer 92(2), 305–311 (2005)Google Scholar
  89. H. Tian, Rapid detection of deletion, insertion, and substitution mutations via heteroduplex analysis using capillary- and microchip-based electrophoresis. Genome Res. 10(9), 1403–1413 (2000)CrossRefGoogle Scholar
  90. M. Tsujiura et al., Circulating microRNAs in plasma of patients with gastric cancers. Br. J. Cancer 102(7), 1174–1179 (2010)CrossRefGoogle Scholar
  91. R. Valenti, Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor—mediated suppressive activity on T lymphocytes. Cancer Res. 66(18), 9290–9298 (2006)CrossRefGoogle Scholar
  92. G.M. Walker, H.C. Zeringue, D.J. Beebe, Microenvironment design considerations for cellular scale studies. Lab Chip 4(2), 91–97 (2004)CrossRefGoogle Scholar
  93. S.J. Wang et al., Differential effects of EGF gradient profiles on MDA-MB-231 breast cancer cell chemotaxis. Exp Cell Res 300(1), 180–189 (2004)CrossRefGoogle Scholar
  94. M.M. Wang et al., Microfluidic sorting of mammalian cells by optical force switching. Nat. Biotechnol. 23(1), 83–87 (2005)CrossRefGoogle Scholar
  95. R. Weinberg, The Biology of Cancer (Garland Science, New York, 2006)Google Scholar
  96. P.T. Went et al., Frequent EpCam protein expression in human carcinomas. Hum. Pathol. 35(1), 122–128 (2004)CrossRefGoogle Scholar
  97. P. Went et al., Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br. J. Cancer 94(1), 128–135 (2006)CrossRefGoogle Scholar
  98. A.K. White et al., High-throughput microfluidic single-cell RT-qPCR. Proc. Natl. Acad. Sci. U. S. A. 108(34), 13999–14004 (2011)CrossRefGoogle Scholar
  99. G.M. Whitesides, The origins and the future of microfluidics. Nature 442(7101), 368–373 (2006)CrossRefGoogle Scholar
  100. D. Wlodkowic, Z. Darzynkiewicz, Microfluidics: emerging prospects for anti-cancer drug screening. World J Clin Oncol 1(1), 18–23 (2010)CrossRefGoogle Scholar
  101. D. Wlodkowic et al., Biological implications of polymeric microdevices for live cell assays. Anal. Chem. 81(23), 9828–9833 (2009a)CrossRefGoogle Scholar
  102. D. Wlodkowic et al., Microfluidic single-cell array cytometry for the analysis of tumor apoptosis. Anal. Chem. 81(13), 5517–5523 (2009b)CrossRefGoogle Scholar
  103. D. Wlodkowic, J. Skommer, Z. Darzynkiewicz, Cytometry in cell necrobiology revisited. Recent advances and new vistas. Cytom. A 77(7), 591–606 (2010)CrossRefGoogle Scholar
  104. A.P. Wong et al., Partitioning microfluidic channels with hydrogel to construct tunable 3-D cellular microenvironments. Biomaterials 29(12), 1853–1861 (2008)CrossRefGoogle Scholar
  105. T.K.F. Yung et al., Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients. Clin. Cancer Res. 15(6), 2076–2084 (2009)CrossRefGoogle Scholar
  106. G. Zheng et al., Multiplexed electrical detection of cancer markers with nanowire sensor arrays. Nat. Biotechnol. 23(10), 1294–1301 (2005)CrossRefGoogle Scholar
  107. S. Zheng et al., Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J. Chromatogr. A 1162(2), 154–161 (2007)CrossRefGoogle Scholar
  108. S. Zheng et al., 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood. Biomed. Microdevices 13(1), 203–213 (2011)CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Chemical EngineeringUniversity of MichiganAnn ArborUSA

Personalised recommendations